Oncology Annual Education- Oncology Navigators
The patient is receiving active chemotherapy. Who needs to exercise hazardous drug (HD) precautions?
All team members that may come in contact with HD or BBF
The nurse is caring for a patient receiving Rituximab. Which adverse reaction will the nurse look out for?
Cytokine Release Syndrome (CRS)
Blinatumomab is classified as ____ therapy, and engages the patient's ______ to kill the cancer.
BiTE; T-cells